Skip to main content

Table 2 Interaction as determined by means of checkerboard assay

From: In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureussevere respiratory infections

Combination

Nr of MRSA strains (%) for which combinations gave

 

Synergy

No interaction

Antagonism

LVX + VA (n = 50)

16 (32)

34 (68)

0

LVX + TEC (n = 50)

9 (18)

41 (82)

0

CTX + VA (n = 50)

23 (46)

27 (54)

0

CTX + TEC (n = 50)

43 (86)

7 (14)

0

LVX + VA + AMK (n = 25)

5 (20)

20 (80)

0

LVX + TEC + AMK (n = 25)

10 (40)

15 (60)

0

LVX + VA + CAZ (n = 25)

15 (60)

10 (40)

0

LVX + TEC + CAZ (n = 25)

20 (80)

5 (20)

0

LVX + VA + FEP (n = 25)

10 (40)

15 (60)

0

LVX + TEC + FEP (n = 25)

10 (40)

15 (60)

0

LVX + VA + IPM (n = 25)

5 (20)

20 (80)

0

LVX + TEC + IPM (n = 25)

10 (40)

15 (60)

0

LVX + VA + TZP (n = 25)

5 (20)

20 (80)

0

LVX + TEC + TZP (n = 25)

20 (80)

5 (20)

0

  1. LVX: levofloxacin; VA: vancomycin; TEC: teicoplanin; CTX: cefotaxime; AMK: amikacin; CAZ: ceftazidime; FEP: cefepime; IPM: imipenem; TZP: piperacillin/tazobactam.